Author:
Meshinchi Soheil,Smith Franklin O.,Arceci Robert J.
Publisher
Springer Science and Business Media LLC
Reference83 articles.
1. Webb DK, Wheatley K, Harrison G, et al.: Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party. Leukemia 1999, 13:25–31.
2. Wheatley K, Burnett AK, Goldstone AH, et al.: A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council’s Adult and Childhood Leukaemia Working Parties. Br J Haematol 1999, 107:69–79.
3. Davies SM, Alonzo TA, Lange B, et al.: Reduced survival in black children with acute myeloid leukemia [abstract]. Blood 2002, 91:122(a).
4. Drabkin HA, Erickson P: Down syndrome and leukemia: an update. Prog Clin Biol Res 1995, 393:169–176.
5. Creutzig U, Ritter J, Ludwig WD, et al.: Acute myeloid leukemia in children with Down syndrome. Klin Padiatr 1995, 207:136–144.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献